Beranda › Fenilketonuria › Texas
Uji klinis Fenilketonuria di Texas
7 studi untuk Fenilketonuria mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
- University of Texas Southwestern Medical Center (UTSW), Dallas
Menerima pesertaFase 1
Usia 18 hingga 69 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07241234AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
- University or Texas, Southwestern medical Center, Dallas
Menerima pesertaFase 1/2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06332807A Study of JNT-517 in Participants With Phenylketonuria (PKU)
- University of Texas Southwestern, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06971731Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- UT Southwestern Medical Center, Dallas
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07477691A Long-Term Study of JNT-517 in Participants With Phenylketonuria
- Children's Medical Center Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health (UTHealth) Science Center at Houston, Houston
Menerima pesertaFase 3
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT06628128A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 25 Mar 2026 · NCT05813678A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- UT Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06305234Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.